Precision Passed—SMS Lifesciences Hits USFDA Bullseye for Export Boost

SMS Lifesciences India Ltd. announced the receipt of an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA), accompanied by a Voluntary Action Indicated (VAI) classification. This regulatory milestone enables the company to expand its exports to the United States and other regulated global markets, reinforcing its position as a trusted manufacturer of Active Pharmaceutical Ingredients (APIs).

 

What the EIR & VAI Status Mean

Strategic Impact

Company Commentary

“This EIR is a testament to our commitment to quality and global standards. It strengthens our ability to serve regulated markets and expand our international footprint,” said a company spokesperson.

 

Sources: SMS Lifesciences, Screener, ZaubaCorp, Trendlyne, Bloomberg